PRESS RELEASE published on 09/28/2023 at 22:15 from NANOBIOTIX NANOBIOTIX Announces Presentation of First Data From Phase 1 Study Evaluating NBTXR3 for Patients With Locally Advanced Pancreatic Cancer
